Skip to main content
SpringerLink
Log in

5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats

  • Original Investigation
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Rationale and objective

Performance on the Wisconsin Card Sorting Test (WCST), which requires patients to ‘shift attention’ between stimulus dimensions (sorting categories), is impaired in diseases such as schizophrenia. The rat attentional set shifting task is an analogue of the WCST. Given that 5-HT6 receptor antagonists improve cognitive performance and influence cortical neurochemistry in rats, the present study investigated the effects of 5-HT6 receptor antagonists upon attentional set shifting in rats.

Methods

Rats were tested in this paradigm following sub-chronic SB-399885-T or SB-271046-A (both 10 mg kg−1 bid, p.o. for 8 days prior to testing and either 4 or 2 h prior to testing on day 9, respectively). Rats were trained to dig in baited bowls for a food reward and to discriminate based on odour or digging media (Habituation, day 8). In a single session (day 9), rats performed a series of discriminations, including reversals (REV), intra-dimensional (ID) and extra-dimensional (ED) shifts.

Results

Neither compound altered performance during Habituation. On the test day, both SB-399885-T and SB-271046-A reduced the total trials to reach criterion and the total errors made when data were collapsed across all discriminations (P<0.05–0.01). Further, both compounds significantly reduced the trials to criterion for REV-1 (P<0.05–0.01) and abolished the ID/ED shift. SB-399885-T, but not SB-271046-A, reduced trials required to complete the ED shift (P<0.05) and the number of errors made during completion of the ID (P<0.05) and ED shifts (P<0.01).

Conclusion

5-HT6 receptor antagonists improved performance in the attentional set shifting task and may have therapeutic potential in the treatment of disorders where cognitive deficits are a feature, including schizophrenia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  • Barense MD, Fox MT, Baxter MG (2002) Aged rats are impaired on an attentional set-shifting task sensitive to medial frontal cortex damage in young rats. Learn Mem 9:191–201

    Article  PubMed  Google Scholar 

  • Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083–1152

    Article  PubMed  CAS  Google Scholar 

  • Bentley JC, Sleight AJ, Marsden CA, Fone KCF (1997) 5-HT6 antisense oligonucleotide i.c.v. affects rat performance in the water maze and feeding. J Psychopharmacol 11:A64

    Google Scholar 

  • Bentley JC, Bourson A, Boess FG, Fone KCF, Marsden CA, Petit N, Sleight AJ (1999) Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist RE 04-6790 in rats. Br J Pharmacol 126:1537–1542

    Article  PubMed  CAS  Google Scholar 

  • Berg EA (1948) A simple objective treatment for measuring flexibility in thinking. J Gen Psychol 39:15–22

    Article  CAS  PubMed  Google Scholar 

  • Birrell JM, Brown VJ (2000) Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci 20(11):4320–4324

    PubMed  CAS  Google Scholar 

  • Bourson A, Borroni E, Austin RH, Monsma F Jr, Sleight AJ (1995) Determination of the role of the 5-HT6 receptor in the rat brain: a study using antisense oligonucleotides. J Pharmacol Exp Ther 274:173–180

    PubMed  CAS  Google Scholar 

  • Bourson A, Boess FG, Bos M, Sleight AJ (1998) Involvement of 5-HT6 receptors in nigro-striatal function in rodents. Br J Pharmacol 125:1562–1566

    Article  PubMed  CAS  Google Scholar 

  • Bromidge SM, Brown AM, Clarke SE, Dodgson K, Gager T, Grassam HL, Jeffrey PM, Joiner GF, King FD, Middlemiss DN, Moss SF, Newman H, Riley G, Routledge C, Wyman P (1999) 5-Chloro-N-(4-methoxy-3-piperazin-1-yl-phenyl)-3-methyl-2-benzothiophenesulfonamide (SB-271046): a potent, selective, and orally bioavailable 5-HT6 receptor antagonist. J Med Chem 42(2):202–205

    Article  PubMed  CAS  Google Scholar 

  • Foley AG, Murphey KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS, Regan CM (2004) The 5-HT6 receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats. Neuropsychopharmacology 29(1):93–100

    Article  PubMed  CAS  Google Scholar 

  • Fox MT, Barense MD, Baxter MG (2003) Perceptual attentional set-shifting is impaired in rats with neurotoxic lesions of the posterior parietal cortex. J Neurosci 23(2):676–681

    PubMed  CAS  Google Scholar 

  • Frederick JA, Meador-Woodruff JH (1999) Effects of clozapine and haloperidol on 5-HT6 receptor mRNA levels in the rat brain. Schizophr Res 38:7–12

    Article  PubMed  CAS  Google Scholar 

  • Gerard C, El Mestikawy S, Lebrand C, Adrien J, Ruat M, Traiffort B, Hamon M, Martres MP (1996) Quantitative RT-PCR distribution of serotonin 5-HT6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytruptamine-treated rats. Synapse 23(3):164–173

    Article  PubMed  CAS  Google Scholar 

  • Gerard C, Martres MP, Lefevre K, Miquel MC, Verge D, Lanfumey L, Doucet E, Hamon M, El Mestikawy S (1997) Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res 746:207–219

    Article  PubMed  CAS  Google Scholar 

  • Hamon M, Doucet E, Lefevre K, Miquel MC, Lanfumey L, Insausti R, Frechilla D, Del Rio J, Verge D (1999) Antibodies and antisense oligonucleotide for probing the distribution and putative functions of central 5-HT6 receptor. Neuropsychopharmacology 21:68–76

    Google Scholar 

  • Hatcher PD, Brown VJ, Tait DS, Jones DNC (2002) 5-HT6 receptor antagonists improve performance in an attentional set shifting task. J Psychopharmacol 16(3):A16

    Google Scholar 

  • Hirst WD, Stean TO, Rogers DC, Sunters D, Pugh P, Moss SF, Bromidge SM, Riley G, Smith DR, Barlett S, Heidbreder CA, Atkins AR, Lacroix LP, Dawson LA, Foley AG, Regan CM, Upton N. SB-399885 is a potent, selective 5-HT6 receptor antagonist active in rat water maze and novel object recognition models, Br J Pharmacol (personal communication)

  • Jay TM (2003) Dopamine: a potential substrate for synaptic plasticity and memory mechanisms. Prog Neurobiol 69(6):375–390

    Article  PubMed  CAS  Google Scholar 

  • Kolb B, Wilshaw IQ (1983) Performance of schizophrenic patients on tests sensitive to left or right frontal temporal, or parietal function in neurological patients. J Nerv Ment Dis 171:435–443

    Article  PubMed  CAS  Google Scholar 

  • Lacroix LP, Dawson LA, Hagan JJ, Heidbreder CA (2004) 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51(2):158–164

    Article  PubMed  CAS  Google Scholar 

  • Lindner MD, Hodges DB, Hogan JB, Orie AF, Corsa JA, Barten DM, Polson C, Robertson BJ, Guss VL, Gillman KW, Starrett JE, Gribkoff VK (2003) An assessment of the effects of serotonin 6 (5-HT6) receptor antagonists in rodent models of learning. J Pharmacol Exp Ther 307(2):682–691

    Article  PubMed  CAS  Google Scholar 

  • McAlonan K, Brown VJ (2003) Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat. Behav Brain Res 146(1–2):97–103

    Article  PubMed  Google Scholar 

  • Meltzer HY, McGurk SR (1999) The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Schizophr Bull 25(2):233–255

    PubMed  CAS  Google Scholar 

  • Meneses A (2001) Effects of the 5-HT6 receptor antagonist RO 04-6790 on learning consolidation. Behav Brain Res 118:107–110

    Article  PubMed  CAS  Google Scholar 

  • Pantelis C, Barber FZ, Barnes TRE, Nelson HE, Owen AM, Robbins TW (1999) Comparison of set shifting ability in patients with chronic schizophrenia and frontal lobe damage. Schizophr Res 37:251–270

    Article  PubMed  CAS  Google Scholar 

  • Pare D (2003) Role of the basolateral amygdala in memory consolidation. Prog Neurobiol 70(5):409–420

    Article  PubMed  CAS  Google Scholar 

  • Ragozzino ME, Wilcox C, Raso M, Kesner RP (1999) Involvement of rodent prefrontal cortex subregions in strategy switching. Behav Neurosci 113:32–41

    Article  PubMed  CAS  Google Scholar 

  • Regan CM, Foley AG, Murphy KJ, Hirst WD, Gallagher HC, Hagan JJ, Upton N, Walsh FS (2003) The 5-HT6 receptor antagonists SB-271046 and SB-399885 increase basal and learning induced NCAM-polysialylation in the rat dentate gyrus. Society for Neuroscience No. 835.21

  • Riemer C, Borroni E, Levet-Treafit B, Martin JR, Poli S, Porter RHP, Bos M (2003) Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterisation 4-(2-Bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist. J Med Chem 46:1273–1276

    Article  PubMed  CAS  Google Scholar 

  • Roberts AC, Robbins TW, Everitt BJ (1988) The effects of intradimensional and extra-dimensional shifts on visual discrimination learning in humans and non-human primates. Q J Exp Psychol 40B:321–341

    Google Scholar 

  • Rogers DC, Hagan JJ (2001) 5-HT6 receptor antagonists enhance retention of a water maze task in the rat. Psychopharmacology 158(2):114–119

    Article  PubMed  CAS  Google Scholar 

  • Roth BL, Criago SC, Choudhary MS, Uluer A, Monsma FJ, Shen Y, Meltzer HY, Sibley DR (1994) Binding of typical and atypical antipsychotic agents to 5-HT6 and 5-HT7 receptors. J Pharmacol Exp Ther 268:1403–1410

    PubMed  CAS  Google Scholar 

  • Roth BL, Sheffler DJ, Kroeze WK (2004) Magic shotgun versus magic bullets: selectively non-selective drugs for mood disorders and schizophrenia. Nat Rev 3:353–359

    CAS  Google Scholar 

  • Routledge C, Bromidge SM, Moss SF, Price GW, Hirst WD, Newman H, Riley G, Gager T, Stean TO, Upton N, Clarke SE, Brown AM, Middlemiss DN (2000) Characterisation of SB-271046-A: a potent, selective and orally active 5-HT6 receptor antagonist. Br J Pharmacol 130:1606–1612

    Article  PubMed  CAS  Google Scholar 

  • Ruat M, Traiffort E, Arrang JM, Tardivel-Lacombe J, Diaz J, Leurs Schwartz JC (1993) A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem Biophys Res Commun 193(1):268–276

    Article  PubMed  CAS  Google Scholar 

  • Ward RP, Hamblin MW, Lachowicz JE, Hoffman BJ, Sibleys DR, Dorsa DM (1995) Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64(4):1105–1111

    Article  PubMed  CAS  Google Scholar 

  • Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2000) Reversal of a scopolamine-induced deficit in object discrimination by a selective 5-HT6 receptor antagonist, RO-06790, in rats. Br J Pharmacol 129:64P

    Google Scholar 

  • Woolley ML, Bentley JC, Sleight AJ, Marsden CA, Fone KCF (2001) A role for 5-HT6 receptors in retention of spatial learning in the Morris water maze. Neuropharmacology 41:210–219

    Article  PubMed  CAS  Google Scholar 

  • Woolley ML, Marsden CA, Sleight AJ, Fone KCF (2003) Reversal of a cholinergic-induced deficit in a rodent model of recognition memory by the selective 5-HT6 receptor antagonist, Ro 04-6790. Psychopharmacology 170(4):358–367

    Article  PubMed  CAS  Google Scholar 

  • Woolley ML, Marsden CA, Fone KCF (2004) 5HT6 receptors. Curr Drug Targets CNS Neurol Disord 3:59–79

    Article  PubMed  CAS  Google Scholar 

  • Zhukovshaya NL, Neumaier JF (2000) Clozapine downregulates 5-HT6 and upregulates 5-HT7 receptors in HeLa cells. Neurosci Lett 288:236–240

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schizophrenia and Bipolar Disorders Research, Psychiatry CEDD, Harlow, Essex, CM19 5AW, UK

    Paula D. Hatcher, Jim J. Hagan & Declan N. C. Jones

  2. School of Psychology, University of St Andrews, St Andrews, KY16 9JU, UK

    Verity J. Brown & David S. Tait

  3. Statistical Sciences, Europe, GlaxoSmithKline, Harlow, Essex, CM19 5AW, UK

    Simon Bate & Philip Overend

Authors
  1. Paula D. Hatcher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Verity J. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David S. Tait
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Simon Bate
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Philip Overend
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jim J. Hagan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Declan N. C. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Declan N. C. Jones.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hatcher, P.D., Brown, V.J., Tait, D.S. et al. 5-HT6 receptor antagonists improve performance in an attentional set shifting task in rats. Psychopharmacology 181, 253–259 (2005). https://doi.org/10.1007/s00213-005-2261-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00213-005-2261-z

Keywords

Search

Navigation